TrialAnnals of oncology : official journal of the European Society for Medical Oncology2015

Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trials.

Y Sunakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.